BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31365872)

  • 1. CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.
    Jiang C; Trudeau SJ; Cheong TC; Guo R; Teng M; Wang LW; Wang Z; Pighi C; Gautier-Courteille C; Ma Y; Jiang S; Wang C; Zhao B; Paillard L; Doench JG; Chiarle R; Gewurz BE
    Cell Rep; 2019 Jul; 28(5):1307-1322.e8. PubMed ID: 31365872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.
    Duan S; Cermak L; Pagan JK; Rossi M; Martinengo C; di Celle PF; Chapuy B; Shipp M; Chiarle R; Pagano M
    Nature; 2012 Jan; 481(7379):90-3. PubMed ID: 22113614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic psychological stress impairs germinal center response by repressing miR-155.
    Sun W; Zhang L; Lin L; Wang W; Ge Y; Liu Y; Yang B; Hou J; Cheng X; Chen X; Wang Z
    Brain Behav Immun; 2019 Feb; 76():48-60. PubMed ID: 30414952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO11 inactivation leads to abnormal germinal-center formation and lymphoproliferative disease.
    Schneider C; Kon N; Amadori L; Shen Q; Schwartz FH; Tischler B; Bossennec M; Dominguez-Sola D; Bhagat G; Gu W; Basso K; Dalla-Favera R
    Blood; 2016 Aug; 128(5):660-6. PubMed ID: 27166359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma.
    Pighi C; Cheong TC; Compagno M; Patrucco E; Arigoni M; Olivero M; Wang Q; López C; Bernhart SH; Grande BM; Poggio T; Langellotto F; Bonello L; Dall'Olio R; Martínez-Martín S; Molinaro L; Francia di Celle P; Whitfield JR; Soucek L; Voena C; Calogero RA; Morin RD; Staudt LM; Siebert R; Zamò A; Chiarle R
    Blood Adv; 2021 Dec; 5(23):5239-5257. PubMed ID: 34625792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma.
    Christodoulou E; Rashid M; Pacini C; Droop A; Robertson H; Groningen TV; Teunisse AFAS; Iorio F; Jochemsen AG; Adams DJ; Doorn RV
    Pigment Cell Melanoma Res; 2021 Jan; 34(1):122-131. PubMed ID: 32767816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation.
    Sun D; Stopka-Farooqui U; Barry S; Aksoy E; Parsonage G; Vossenkämper A; Capasso M; Wan X; Norris S; Marshall JL; Clear A; Gribben J; MacDonald TT; Buckley CD; Korbonits M; Haworth O
    Cell Rep; 2019 Apr; 27(5):1461-1471.e4. PubMed ID: 31042473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Arginine Methylation by PRMT7 Controls Germinal Center Formation via Regulating Bcl6 Transcription.
    Ying Z; Mei M; Zhang P; Liu C; He H; Gao F; Bao S
    J Immunol; 2015 Aug; 195(4):1538-47. PubMed ID: 26179907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
    Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
    J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells.
    Polo JM; Ci W; Licht JD; Melnick A
    Blood; 2008 Aug; 112(3):644-51. PubMed ID: 18487509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
    Munroe ME; Bishop GA
    J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome.
    Schieber M; Marinaccio C; Bolanos LC; Haffey WD; Greis KD; Starczynowski DT; Crispino JD
    Blood Cancer J; 2020 Oct; 10(10):98. PubMed ID: 33024076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External signals regulate germinal center fate-determining transcription factors in the A20 lymphoma cell line.
    Feng J; Liu X; Ni X; Qi H
    Mol Immunol; 2018 Jan; 93():79-86. PubMed ID: 29154209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
    Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
    J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
    Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
    Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells.
    Kusam S; Munugalavadla V; Sawant D; Dent A
    Int J Cancer; 2009 Aug; 125(4):977-81. PubMed ID: 19405121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
    Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of sphingosine kinase 1 and sphingosine-1-phosphate in CD40 signaling and IgE class switching.
    Kim EY; Sturgill JL; Hait NC; Avni D; Valencia EC; Maceyka M; Lima S; Allegood J; Huang WC; Zhang S; Milstien S; Conrad D; Spiegel S
    FASEB J; 2014 Oct; 28(10):4347-58. PubMed ID: 25002116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions.
    Jalukar SV; Hostager BS; Bishop GA
    J Immunol; 2000 Jan; 164(2):623-30. PubMed ID: 10623803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.